Organization Overview
Alternative names
aldesleukin (proleukin) (1 trial)
allogeneic adipose derived mesenchymal stem cell (1 trial)
autologous cd34+ cells (1 trial)
betaas3-fb vector transduced bm cd34+ cells (1 trial)
cd4+ t-cell-depleted haploidentical hematopoietic cells (1 trial)
Amyotrophic Lateral Sclerosis (Phase 3)
Anemia, Sickle Cell (Phase 1)
Bone Diseases, Metabolic (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Familial Primary Pulmonary Hypertension (Phase 1)
Granuloma (Phase 2)
Granulomatous Disease, Chronic (Phase 2)
Hemoglobinopathies (Phase 1)
Hypertension (Phase 1)
Immunologic Deficiency Syndromes (Phase 2)
Infarction (Phase 2)
Motor Neuron Disease (Phase 3)
Myocardial Infarction (Phase 2)
Neoplasms (Phase 1)
Osteonecrosis (Phase 1)
Osteoporosis (Phase 1)
Sarcoma (Phase 1)
Sclerosis (Phase 1)
Severe Combined Immunodeficiency (Phase 2)
Thalassemia (Phase 1)
Ventricular Dysfunction (Phase 2)